Impact Factor 5.511

Among the world's top 10 most-cited Immunology journals

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Immunol. | doi: 10.3389/fimmu.2018.02461

Regulatory T cells suppress effector T cell proliferation by limiting division destiny

  • 1Walter and Eliza Hall Institute of Medical Research, Australia

Understanding how the strength of an effector T cell response is regulated is a fundamental problem in immunology with implications for immunity to pathogens, autoimmunity and immunotherapy. The initial magnitude of the T cell response is determined by the sum of independent signals from antigen, co-stimulation and cytokines. By applying quantitative methods, the contribution of each signal to the number of divisions T cells undergo (division destiny) can be measured, and the resultant exponential increase in response magnitude accurately calculated. CD4+CD25+Foxp3+ regulatory T cells (Tregs) suppress self-reactive T cell responses and limit pathogen-directed immune responses before bystander damage occurs. Using a quantitative modelling framework to measure T cell signal integration and response, we show that Tregs modulate division destiny, rather than directly increasing the rate of death or delaying interdivision times. The quantitative effect of Tregs could be mimicked by modulating the availability of stimulatory co-stimuli and cytokines or through the addition of inhibitory signals. Thus, our analysis illustrates the primary effect of Tregs on the magnitude of effector T cell responses is mediated by modifying division destiny and survival of responding cell populations.

Keywords: T cells, regulatory T cells (T-Regs), modeling & simulation, Cytokines, Immunity

Received: 07 Jun 2018; Accepted: 04 Oct 2018.

Edited by:

Benny Chain, University College London, United Kingdom

Reviewed by:

Grégoire Altan-Bonnet, Division of Cancer Biology (NCI), United States
Rob J. De Boer, Utrecht University, Netherlands
David Sansom, University College London, United Kingdom  

Copyright: © 2018 Dowling, Kan, Heinzel, Marchingo, Hodgkin and Hawkins. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Dr. Mark Dowling, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia,
Dr. Edwin D. Hawkins, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia,